CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery.
CardiaTec Biosciences has raised $6.5M in total funding. The most recent round was Seed. The last funding was announced in September 2024.
CardiaTec Biosciences's investors include Montage Ventures, O2h Ventures, University of Cambridge Enterprise, Crista Galli Ventures, Continuum Health Ventures.
CardiaTec Biosciences is headquartered in Cambridge, United Kingdom.
CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery.
CardiaTec Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CardiaTec Biosciences — Funding & Investors." VCBacked, September 10, 2024, https://www.vcbacked.co/company/cardiatec-biosciences. Accessed July 19, 2026.
VCBacked. (2024). CardiaTec Biosciences — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/cardiatec-biosciences
{{cite web |title=CardiaTec Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/cardiatec-biosciences |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated